@17'50" "In the rest of the world, we do about 200k patients per annum, we sell per patient consumable around 55 ausie, in the US we're going to be able to demand around 140 US dollars per patient"
https://******.com.au/media/richards-stock-picks-cyclopharmas-fda-nod-moors-small-comeback?videoId=32039
USD140 is about 222 ausie at today's rate, more than 4 times the price for the rest of the world.
Ann: SNMMI Announcement Regarding USFDA Approval of Technegas, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
91.0¢ |
Change
-0.040(4.21%) |
Mkt cap ! $101.1M | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 97.0¢ | 90.0¢ | $177.9K | 194.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1210 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 1661 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |